Member Info for Saxondale

During may Q&A's over the years , the consensus seemed to be that a company with a pioneering immunotherapy drug like Bex , that could be proven effective , commercialised and had multiple other combination opportunities in oncology would be worth $1-2 billion . The cancer Immunotherapy market is growing massively . I think Markku's last presentation in the UK he spoke of $50 billion market Bex could be applied to . The whole cancer Immunotherapy market is nearer$125 billion and expected to grow 18% a year . A partnership deal won't realise that value straight away , but if it puts Faron into the category of profit making and generating cash for future growth , then why not a £10 SPin the near future ?. Thats only a $700m Mcap . This partner deal may be only one of many to come , if it isn't a big exclusive tie up . So maybe one step at a time . ( Disclaimer - we've all been here long enough to know that until we get the big RNS - anything might nothing may happen lol )

Yes , been good steady demand on Nas , couple of massive days , now running at about 200k a day . Setting up nicely for next week .

I think someone mentioned a while ago that we were on one of those trading platforms now ( like E toro) . That would explain lots of little buys and sells , which often come in clumps as they get cleared through the system .

Also pages like this , where like it or not , as steam builds , so we will get traders coming in for the swings .

Hopefully not too erratic and silly . The free float here is pretty small . Given what may be coming , £2 is still in the foothills of where the SP could get to .

https://www.tradingview.com/symbols/LSE-FARN/technicals/

Yes its the week starting the 20th for next data .

But we all know its good anyway - they've pretty much told us that .

Maybe this movement is either adjusting back to pre hiccup levels now confidence is back and ship is steady , along with CEO making positive bold statement , and expectation that at some point in the next few months - we will be partnered .

Sometimes you have to wonder why the SP moves . Not complaining , but perhaps wheels are moving behind the scenes .

Multiple parties are in discussions with Faron .

Nearly 38% up on the day - 2.555 euro ( £2.16 by my usual calc)

Lets hope the promised SSV mk2 eventually makes us all very rich .

Nearly 550,000k volume on Naz - and 32% up on the day .

If we get to pre hiccup price of £2.65 by end of next week , that would be nice , and we can all pretend that it was just a bad dream lol .

200,000 vol now on Nas . Still a week away from results .

Have a good trip Western . Hopefully the next results will increase the confidence of success even further , and it's this sort of derisking that should keep pushing the SP back up to where it was before . Bexmab really has been a lifesaver in more than one way .

Also checked the status of the most recent trademark applications in the US , and they are now finally approved and registered as of about 10 days ago ( takes a long time). So at least that is sorted ready for any future roll out .

I've been off for a bit , but just checked Farons calendar , and they have 3 events listed in the next few weeks , ASCO , BIO International , and EHA congress .

https://www.faron.com/investors/event-calendar

Pretty sure 2024 will be transformational for Faron .

If the hiccup hadn't happened , maybe Markku would have stayed on a little longer to take some glory , but as it did happen , best to pass the baton over to fresh hands ( although its all the same family ), and let the new CEO start his journey with some real positive successes . Juho will be keen to show he is 'the man ' now too . The first partnership ( which he seems very confident on) , following clear FDA advice on approval route for MDS , should get the brakes off , and let Faron start progress on all their other plans fro Bex . I think Juho is more businessman than scientist , which is what Faron needs now in a CEO .

Hi Speedie . only pop in here now and again while we wait for news . Thanks for bringing some sanity lol .

And thanks to the fudsters I now have more shares here than I've ever owned , and at the lowest price .

Can't wait for the next chapter !

Well he's got about 3.3 million shares , so when SSV lands , he'll be in the money .

So the baton is passed to Juho .

Farewell to Markku . Shame he has left under a bit of a shadow - but in the long run I expect people will look back and forget the hiccup . To be honest , hiccup or not , its logical for him to move on , and let the new blood get to take on the task in hand . Dr Juho is a good character , and a great communicator too .

SP aside , I thank him for his efforts and hope he enjoys his retirement .

The day Timo starts selling is the day I go too .

Fair play to the guy - he's in for the long haul . I don't see him selling any until its mission accomplished here , be that a takeover , or major rerate to a far different level . His stake is too big anyway to dispose of without crushing the SP .

The coming placing will set them up for the rest of the year I guess . But thats not saying a deal won't be done 'before' that . Bexmab data will be accruing on a monthly basis .

The placing has been announced for weeks now . So its not going to be a surprise to anyone . SP will be in a holding position now . You could now sell and hope to get in lower . That might work , but for the sake of 10-15p , you might as well just hold on . Who is going to want to sell sub placing price - when all the newsflow coming from now onwards should be positive ?

Not sure how they have achieved this 25% saving in employee costs ? Possibly management have tightened their belts , or deferred some of their benefits ( Markku is not taking a salary at present ) . I don't see them cutting a quarter of the workforce . Cutting the conference attendances , show trips etc and hobnobbing events will probably save a fair amount .

20% overall reduction . Which as pointed out is quite prudent , as their cash burn ( with the accelerated push ) has been high .

Faron has completed an overall cost reduction plan that eliminated over 20% of operating expenses including a 25% reduction in employee-related expenditure. Cash burn for the first half of 2024 is estimated at EUR 2.5 million per month declining to approximately EUR 2.0 million per month in the second half of the year.

Well , we knew the jam wasn't going to be today . At least we know there is some jam , and investors out there ready to step up and fund us .

Good to see EIC still involved and actively helping out .

So now they can crack on with the other 27m ( probably at around 1.50 I expect )

Then the SP may start working its way up as the market starts getting excited about either Faron getting a drug to market at long last , or one of the circling partners finally making a play .

With preference to existing shareholders however , it will be interesting to see how the SP reacts , as once the funding is done , the SP shouldn't sit at this level for too long

Pretty sure they have to put that kind of disclaimer in . Either way . SP hasn't tanked further , so assume most ( like me) are just holding now for AGM .

Its only 3 trading days until that AGM ( next Friday)

Then they should be able to pass resolutions to allow the proper fundraise to be put into action - or gives them the ammunition for any partnership tie up ( ie with equity ).

Cracking interview .

Expect further FDA designations soon ( applied for already we know)

Its easy to forget , but its only at this stage in the trial that Faron finally get to see proof that Bex is still doing its job ( not fading away) . I think that certain interested parties wanted to see that proof . As he says , negotiations are intensifying .